GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
Whoops……Ripley. :-)
Ridley
Because an investor could effectively get his hands on a lot more shares by buying the rights. I’m sure one couldn’t just buy 130 mil shares in the company on the open market, but one could buy the rights. No problem if one is dealing in less than a mill shares, but more than that could be very difficult without the price going through the roof. Just my opinion on the matter.
Morning The.Italian,
I think you are probably right regarding the registered in own name bit. Most overseas investors or those that were part of the PLE TO probably ended up grouped through a few nominee accounts. ERP, I feel, didn’t want to go to all the trouble of getting shareholder information from them hence the statements about getting named certificates and registering an interest. But of course it’s really anybodies guess what the clowns were really trying to say. Certainly confusing as usual.
There were 130mill up for 0.01hkd, so I offered mine for the same, however. There don’t appear to be any takers.
It’s probably the way the first announcement was written ie not being offered to overseas investors, however. It would seem it was the usual smoke n mirror vagueness by JG. Usually done on purpose.
I wasn’t going to participate since they have let shareholders down so many times before that I now consider it as high risk again.
You do realise that in March 2014 they had an announcement called FDA unambiguous way forward, followed by an announcement that they would obtain FDA approval mid 2017, which should have been delayed by a year due to a cokc-up with a 6 dose canister and have been promising FDA approval each year ever since. Subsequently phase II has so far taken 4 years and shareholders are still non the wiser.
Morning The.Italian
He did get one thing right with his ref to con men though…..lol
Hammer time, I
think you’ve got the wrong board since a raise is already in play.
Best you “Don’t touch this”….lol
Morning The.Italian.
I wasn’t sure of my standing since although I am resident, my shares are held by a nominee out from the UK., wifey, however is more eligible being Singaporean.
That said, I probably won’t participate given it’s become very high risk again, even with the expected news. Since track record has shown that even with positive news, the management will somehow manage to **** it all up.
Also, given the current SP and market cap, which has jumped 2 fold one the additional shares were added, I fully expect it to drop further, which has always been the case when the company has gone through the process. So even if I were thinking of buying any shares, I will probably be able to get them far cheaper come the new year.
Again with the current situation in China where everyone will be tightening their belts, I’m sure initial sales will be nowhere near what is expected. The same I think could happen in the US. The US marketing report which is now 2.5years old is well out of date regarding what insurance companies would be willing to cough up, although it would appear to have been of no use whatsoever anyway.
Yes he and his band of thieves will own around 59% of the company using the approved whitwash waiver.
Have you not even read the reason for the rights issue....cough...???
Underwriter and parties acting in concert with it in the Company upon the close of the Rights Issue will increase from the current level of approximately 25.15% to approximately 59.87% of the issued share capital of the Company as enlarged by the issue of the Rights Shares.
http://www.endurancerp.com/ICMServlet/download/13-2625-4265/ew_00575Ann-26092022.pdf
Morning The.Italian.
More like a great deal of carnage, if you ask me.
I’m certainly not surprised there is still no prospectus. I’m sure they would want to hang on to any contained information as long as possible. The less private investors put in may leave more to be handed out elsewhere under the table, if you get my meaning. ;-)
The.Italian,
I don't think its a case of jaws of defeat, but more like the jaws of failure since there has been no battle just incompetence.....lol
As you state luck does indeed have a huge part to play, however. If we consider the 6 dose can failure as being unlucky (we still had the 20 dose can that worked) and the unlucky 5 years of manufacturing problems (5 years one askes....yes 5 years and they still couldn't find the problem and it too a 3rd party to solve it in only a few months) then maybe Id agree. Unfortunately, the 6 dose can failure only added 9 months to the result and the manufacturing issue I am sure, with the correct qualified personnel, should have been sorted a long time ago. That then leaves the managements inability to bring this all to a conclusion, which, I would say has nothing to do with luck.
The.Italian,
It certainly looks and reads that FUM is steaming ahead with their product. So much so, they have license agreements coming out their ears. FUM certainly makes our crowd look like a bunch of clowns. FUM currently has a market cap of 144mil gbp Nearly 4 times that of ERP and yet we are meant to have a better product given the difference in competition between PE and ED.
Some have called it snake oil, yet licensees still appear to be lining up to get on board. The biggest difference is their management appear to be highly motivated and know what they are doing, compared to our bunch of headless chickens.
Dougie, you are obviously not reading the posts.
Shareholders won’t hear anything until after the rights issue next year. There may be something in the upcoming prospectus to convince existing shareholders to take up the rights, but I’m pretty sure it will be the usual smoke and mirror vagueness as we have seen before. I’m also pretty sure there will be no news on any us license until Jim etc have received their share certificates…..
Interestingly if Jim and the club, including the new DLI members take up their rights, there will be less than 25% free float shares available for trade as I’m sure none of them will offload till there’s an income stream and a huge rerate on sp. just my opinion of course, but we all know what to expect now given their past history.
Another 3 x 10k share transactions at close to keep the sp around the placing price. One would have to be blind to miss how obvious it all is :-O
Well.
We have now entered December which is 4.5 years from the companies alleged start (4 years from the actual start) of phase II and we still have not finished with it and started phase III. This, you must admit, is quite unprecedented and incredible given they only needed 100 subjects. Even with Covid, which I suggest had little impact given that in the first year which was Covid free they only managed to recruit 15 subjects, yet in the main lockdown Covid year, they managed to recruit and process the remaining 85. How on earth can it take a further 2 years to process the data of 100 surjects and get approval to continue to phase III. Damned amazing if you ask me and certainly shows a huge amount of ineptness and incompetence with no real sign of any eagerness to get the product on the shelves. Quit astonishing given its meant to be a block buster. It certainly would appear there has been many typo's and it should be ball buster for us shareholders.
That's my rant for the day.....lol.
If it is indeed the case, the timing certainly would make one wonder if all the recent manipulation (and I include the DLI purchase) has been planned all along leading to their own endgame. I wonder if would have seen the same shenanigans if the fda process had occurred earlier, or has that too been planned and it wasn’t all just incompetence. Worth a thought……but maybe not. Surely they are not that clever…….or are they……lol
I’m sure there won’t be. I’m sure it’s all being controlled this end. Ie the gov website only gets updated by Dr Mike who has already informed me there won’t be any fda news forthcoming until the rights issue is sorted. I’m sure he is under strict instructions not to make any updates.
The. Italian.
Maybe that's what ERP are hoping for, otherwise surely they would have announced some update on progress to help push the price up and encourage uptake. It seems to me that the rights issue is just to clear all the debts (mainly JM and JG) and turn them into shares ready for news in the new year. I'm sure they are probably sitting on a US license agreement (remember how accurate JG was with an amount) and will announce something at the beginning of the new year once the dust settles. With the expected cash injection they will have enough cash up until its approved and sales start. I'm sure they don't give a monkeys ares about all the lowlife private investors, they never have so why change now.
I think this link will be better. Note ticker is 0575
http://www.aastocks.com/en/stocks/quote/detail-quote.aspx?symbol=00575
See
http://www.aastocks.com/en/mobile/quote.aspx?symbol=00575
I’m sure they have to keep the sp above the rights issue price otherwise shareholders who want shares will just buy on the open market to gain that few % difference and ERP wouldn’t then get their every dollar.